Comments

Mineralys Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Mineralys Therapeutics (MLYS) operate in?

Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MLYSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$16.87

0.140.84%

At close: -

$17.15

0.281.66%

After Hours: Mar 21, 7:58 PM EDT

Mineralys Therapeutics (MLYS) Forecast

News Earnings Mineralys Therapeutics (MLYS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Mineralys Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:MLYS | Benzinga

Explore Mineralys Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MLYS.

Open	$16.60
Close	$16.87
Volume / Avg.	832.44K / 792.08K
Day Range	$16.56 - $17.26
52 Wk Range	8.24 - 18.38
Market Cap	$1.08B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	76
Short Interest	4.28%
Days to Cover	4.63

Recent News

Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood pressure reductions and a strong safety profile.

Vandana Singh

Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$16.60
Close	$16.87
Volume / Avg.	832.44K / 792.08K
Day Range	$16.56 - $17.26
52 Wk Range	8.24 - 18.38
Market Cap	$1.08B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	76
Short Interest	4.28%
Days to Cover	4.63

About Mineralys Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medic...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Mineralys Therapeutics (MLYS) stock?

You can purchase shares of Mineralys Therapeutics (NASDAQ:MLYS) through any online brokerage.

View our list of the best stock brokerages

Who are Mineralys Therapeutics (MLYS) competitors?

Other companies in Mineralys Therapeutics’s space includes: 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), Replimune Group (NASDAQ:REPL) and CareDx (NASDAQ:CDNA).

What is the forecast, or price target, for Mineralys Therapeutics (MLYS) stock?

Mineralys Therapeutics has a consensus price target of $33.67.

What is the current price for Mineralys Therapeutics (MLYS)?

The stock price for Mineralys Therapeutics (NASDAQ: MLYS) is $17.15 last updated March 21, 2025 at 7:58 PM EDT.

Does Mineralys Therapeutics (MLYS) pay a dividend?

There are no upcoming dividends for Mineralys Therapeutics.

When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?

Mineralys Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Mineralys Therapeutics (MLYS) going to split?

There is no upcoming split for Mineralys Therapeutics.

What sector and industry does Mineralys Therapeutics (MLYS) operate in?

Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.